Providing education, support, advocacy, and promoting research
for CTX patients, their families, and medical professionals
who treat and study this rare disease.
Newborn screening for cerebrotendinous xanthomatosis is the solution for early identification and treatment
DeBarber AE, Kalfon L, Fedida A, Fleisher Sheffer V, Ben Haroush S, Chasnyk N, Shuster Biton E, Mandel H, Jeffries K, Shinwell ES, Falik-Zaccai TC. Newborn screening for cerebrotendinous xanthomatosis is the solution for early identification and treatment. J Lipid Res. 2018 Nov;59(11):2214-2222. doi: 10.1194/jlr.M087999. Epub 2018 Aug 22. PMID: 30135217; PMCID: PMC6210902.
Join The CTX Alliance
Join our mailing list to receive information and news as we begin to gather and expand the CTX community.
Support the CTX Alliance
1586 Sumneytown Pike
PO Box 1322
Kulpsville, PA 19443
info@ctxalliance.org
Latest CTX Articles
- Apparent underdiagnosis of Cerebrotendinous Xanthomatosis revealed by analysis of ~60,000 human exomes November 18, 2021
- Cerebrotendinous Xanthomatosis September 13, 2021
- Epidemiology, diagnosis, and treatment of cerebrotendinous xanthomatosis (CTX) August 27, 2021
